FMS and FME Related Headlines
Go Back- Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis
- Fresenius Medical Care starts EUR 600 million share buyback program
- Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million
- Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026
- Fresenius Medical Care announces €1 billion share buyback program
- Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months
- Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care
- Fresenius Medical Care reappoints CFO Martin Fischer for five years
- Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer
- Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed
- Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band
- Fresenius Medical Care accelerates share buyback with €415 million tranche
- Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned
- Fresenius Medical Care names Charles Hugh-Jones as global chief medical officer
- Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board
- Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025
- Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025
- Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement
- Fresenius Medical Care invests €312 million in Interwell Health unit
- Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment
- Fresenius Medical Care launches EUR 600 million share buyback program
- Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework
- Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025
- Frenova partners with GENEWIZ for kidney disease genomics research
- Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care
- Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico
FMS and FME Related Press Releases
Go Back- Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis
- Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million
- Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026
- Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months
- Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care
- Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer
- Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed
- Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band
- Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned
- Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board
- Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025
- Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025
- Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement
- Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment
- Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework
- Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025
- Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care
- Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico
FMS and FME Related SEC Filings
Go Back- Form 6-K Fresenius Medical Care For: May 28
- Form SD Fresenius Medical Care
- Form 6-K Fresenius Medical Care For: May 26
- Form 6-K Fresenius Medical Care For: Mar 31
- Form 6-K Fresenius Medical Care For: May 05
- Form 6-K Fresenius Medical Care For: Apr 14
- Form 3 Fresenius Medical Care For: Mar 18 Filed by: Renkewitsch Olga
- Form 6-K Fresenius Medical Care For: Feb 24
- Form IRANNOTICE Fresenius Medical Care
- Form 20-F Fresenius Medical Care For: Dec 31
- Form 6-K Fresenius Medical Care For: Feb 24
- Form 6-K Fresenius Medical Care For: Jan 12
- Form 6-K Fresenius Medical Care For: Dec 10
- Form 6-K Fresenius Medical Care For: Nov 17
- Form 6-K Fresenius Medical Care For: Nov 04
- Form 6-K Fresenius Medical Care For: Sep 30
- Form 6-K Fresenius Medical Care For: Oct 01
- Form 6-K Fresenius Medical Care For: Sep 19
- Form 6-K Fresenius Medical Care For: Aug 11
- Form 6-K Fresenius Medical Care For: Jun 30
- Form 6-K Fresenius Medical Care For: Aug 05
- Form 11-K Fresenius Medical Care For: Dec 31
